226 related articles for article (PubMed ID: 15161353)
1. Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors.
Zhang Y; Jung M; Dritschilo A; Jung M
Radiat Res; 2004 Jun; 161(6):667-74. PubMed ID: 15161353
[TBL] [Abstract][Full Text] [Related]
2. Sensitization to gamma-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells.
Zhang F; Zhang T; Teng ZH; Zhang R; Wang JB; Mei QB
Cancer Biol Ther; 2009 May; 8(9):823-31. PubMed ID: 19270532
[TBL] [Abstract][Full Text] [Related]
3. Modulation of radiation response by histone deacetylase inhibition.
Chinnaiyan P; Vallabhaneni G; Armstrong E; Huang SM; Harari PM
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):223-9. PubMed ID: 15850925
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.
Munshi A; Kurland JF; Nishikawa T; Tanaka T; Hobbs ML; Tucker SL; Ismail S; Stevens C; Meyn RE
Clin Cancer Res; 2005 Jul; 11(13):4912-22. PubMed ID: 16000590
[TBL] [Abstract][Full Text] [Related]
5. Novel HDAC inhibitors with radiosensitizing properties.
Jung M; Velena A; Chen B; Petukhov PA; Kozikowski AP; Dritschilo A
Radiat Res; 2005 May; 163(5):488-93. PubMed ID: 15850409
[TBL] [Abstract][Full Text] [Related]
6. Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci.
Munshi A; Tanaka T; Hobbs ML; Tucker SL; Richon VM; Meyn RE
Mol Cancer Ther; 2006 Aug; 5(8):1967-74. PubMed ID: 16928817
[TBL] [Abstract][Full Text] [Related]
7. A systematic assessment of radiation dose enhancement by 5-Aza-2'-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma.
De Schutter H; Kimpe M; Isebaert S; Nuyts S
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):904-12. PubMed ID: 19215824
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of radiation response in osteosarcoma and rhabdomyosarcoma cell lines by histone deacetylase inhibition.
Blattmann C; Oertel S; Ehemann V; Thiemann M; Huber PE; Bischof M; Witt O; Deubzer HE; Kulozik AE; Debus J; Weber KJ
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):237-45. PubMed ID: 20646843
[TBL] [Abstract][Full Text] [Related]
9. Scriptaid, a novel histone deacetylase inhibitor, enhances the response of human tumor cells to radiation.
Kuribayashi T; Ohara M; Sora S; Kubota N
Int J Mol Med; 2010 Jan; 25(1):25-9. PubMed ID: 19956898
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
[TBL] [Abstract][Full Text] [Related]
11. The histone deacetylase inhibitor, Trichostatin A, enhances radiation sensitivity and accumulation of gammaH2A.X.
Karagiannis TC; Harikrishnan KN; El-Osta A
Cancer Biol Ther; 2005 Jul; 4(7):787-93. PubMed ID: 16082178
[TBL] [Abstract][Full Text] [Related]
12. Valproic acid, a histone deacetylase inhibitor, enhances radiosensitivity in esophageal squamous cell carcinoma.
Shoji M; Ninomiya I; Makino I; Kinoshita J; Nakamura K; Oyama K; Nakagawara H; Fujita H; Tajima H; Takamura H; Kitagawa H; Fushida S; Harada S; Fujimura T; Ohta T
Int J Oncol; 2012 Jun; 40(6):2140-6. PubMed ID: 22469995
[TBL] [Abstract][Full Text] [Related]
13. Rational design and development of radiation-sensitizing histone deacetylase inhibitors.
Jung M; Kozikowski A; Dritschilo A
Chem Biodivers; 2005 Nov; 2(11):1452-61. PubMed ID: 17191946
[TBL] [Abstract][Full Text] [Related]
14. Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.
Xue K; Gu JJ; Zhang Q; Mavis C; Hernandez-Ilizaliturri FJ; Czuczman MS; Guo Y
J Cancer Res Clin Oncol; 2016 Feb; 142(2):379-87. PubMed ID: 26314218
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation.
Seo SK; Jin HO; Woo SH; Kim YS; An S; Lee JH; Hong SI; Lee KH; Choe TB; Park IC
J Thorac Oncol; 2011 Aug; 6(8):1313-9. PubMed ID: 21642861
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitor-mediated radiosensitization of human cancer cells: class differences and the potential influence of p53.
Kim IA; Shin JH; Kim IH; Kim JH; Kim JS; Wu HG; Chie EK; Ha SW; Park CI; Kao GD
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):940-9. PubMed ID: 16467109
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Radiosensitization by HDAC Inhibitors CUDC-101 and SAHA in Pancreatic Cancer Cells.
Moertl S; Payer S; Kell R; Winkler K; Anastasov N; Atkinson MJ
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269745
[TBL] [Abstract][Full Text] [Related]
18. HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT.
Bruzzese F; Leone A; Rocco M; Carbone C; Piro G; Caraglia M; Di Gennaro E; Budillon A
J Cell Physiol; 2011 Sep; 226(9):2378-90. PubMed ID: 21660961
[TBL] [Abstract][Full Text] [Related]
19. Novel mechanisms of apoptosis induced by histone deacetylase inhibitors.
Peart MJ; Tainton KM; Ruefli AA; Dear AE; Sedelies KA; O'Reilly LA; Waterhouse NJ; Trapani JA; Johnstone RW
Cancer Res; 2003 Aug; 63(15):4460-71. PubMed ID: 12907619
[TBL] [Abstract][Full Text] [Related]
20. The effects of SAHA on radiosensitivity in pancreatic cancer cells by inducing apoptosis and targeting RAD51.
Wu Z; Jing S; Li Y; Gao Y; Yu S; Li Z; Zhao Y; Piao J; Ma S; Chen X
Biomed Pharmacother; 2017 May; 89():705-710. PubMed ID: 28267674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]